相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases
Ning Ding et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2019)
PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
Neda Yaghoubi et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
PD-1/PD-L1 blockade rescue exhausted CD8+T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway
Rui Zhao et al.
CELL PROLIFERATION (2019)
Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
Xingming Zhang et al.
BMC CANCER (2019)
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
Jitka Fucikova et al.
CLINICAL CANCER RESEARCH (2019)
Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis
Lianzhou Yang et al.
ONCOTARGETS AND THERAPY (2019)
Cell Counts, rather than Proportion, of CD8/PD-1 Tumor-Infiltrating Lymphocytes in a Tumor Microenvironment Associated with Pathological Characteristics of Chinese Invasive Ductal Breast Cancer
Qingkun Song et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL
Yasuo Takashima et al.
SCIENTIFIC REPORTS (2019)
Morphological lymphocytic reaction, patient prognosis and PD-1 expression after surgical resection for oesophageal cancer
Y. Baba et al.
BRITISH JOURNAL OF SURGERY (2019)
Upregulation of PD-1 follows tumour development in the AOM/DSS model of inflammation-induced colorectal cancer in mice
Mohammad Yassin et al.
IMMUNOLOGY (2019)
Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome
Marwan Fakih et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Immune suppression and reversal of the suppressive tumor microenvironment
Kanako Shimizu et al.
INTERNATIONAL IMMUNOLOGY (2018)
Deregulated Mucosal Immune Surveillance through Gut-Associated Regulatory T Cells and PD-1+ T Cells in Human Colorectal Cancer
Hanae Fujimoto et al.
JOURNAL OF IMMUNOLOGY (2018)
Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis
Ei Miyamoto et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-kappa B/IL-6/STAT3 axis
Hualin Zhang et al.
ONCOGENE (2018)
Downregulated Tim-3 expression is responsible for the incidence and development of colorectal cancer
Ping Zhang et al.
ONCOLOGY LETTERS (2018)
Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis
Jonna Berntsson et al.
ONCOIMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Immunotherapy in colorectal cancer: for the select few or all?
Sukeshi Patel Arora et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression
Muming Yu et al.
MOLECULAR MEDICINE REPORTS (2017)
Co-expression of TIM-3 and CEACAMI promotes T cell exhaustion in colorectal cancer patients
Yang Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
Vikram R. Juneja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer
Dagmar Kollmann et al.
ONCOIMMUNOLOGY (2017)
Deubiquitination and Stabilization of PD-L1 by CSN5
Seung-Oe Lim et al.
CANCER CELL (2016)
Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma
Lik Hang Lee et al.
MODERN PATHOLOGY (2016)
TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3/Snail signaling pathway
Baoen Shan et al.
ONCOLOGY REPORTS (2016)
The role of lymphangiogenesis and angiogenesis in tumor metastasis
Roman Paduch
CELLULAR ONCOLOGY (2016)
Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer A Meta-Analysis
Yaxiong Zhang et al.
MEDICINE (2015)
Immunoscore® as a predictor of response to chemotherapy in stage II and stage III colon cancer
Bernhard Mlecnik et al.
Journal for ImmunoTherapy of Cancer (2015)
Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
Danielle M. Lussier et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines
Julien Fourcade et al.
CANCER RESEARCH (2014)
PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
Cecile Badoual et al.
CANCER RESEARCH (2013)
Molecular mechanisms and imaging of lymphatic metastasis
Steven T. Proulx et al.
EXPERIMENTAL CELL RESEARCH (2013)
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
Hang Li et al.
HEPATOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization
Lukas Baitsch et al.
PLOS ONE (2012)
Risk Factors for Postoperative Recurrence in Patients with Pathologically T1 Colorectal Cancer
Shuji Iida et al.
WORLD JOURNAL OF SURGERY (2012)
Emerging Tim-3 functions in antimicrobial and tumor immunity
Kaori Sakuishi et al.
TRENDS IN IMMUNOLOGY (2011)
Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer
Yan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
Xiaoyuan Huang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer
Martin Loos et al.
BMC CANCER (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
PD-1: an inhibitory immunoreceptor involved in peripheral tolerance
H Nishimura et al.
TRENDS IN IMMUNOLOGY (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
